GL
PFE icon

GLG LLC’s Pfizer PFE Stock Holding History

GLG LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-843,200
Closed -$23.7M – 631
2014
Q3 		$23.7M Sell
843,200
-99,392
-11% -$2.79M 0.63% 33
2014
Q2 		$26.5M Buy
942,592
+315,989
+50% +$9.01M 0.78% 18
2014
Q1 		$19.1M Buy
+626,603
New +$18.7M 0.64% 28

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GLG LLC's PFE Position: Q4 2017 in Review

GLG LLC held its Pfizer (PFE) position steady in Q4 2017 at 306,820 shares worth $10.5M. The position accounts for 0.76% of the portfolio, ranked #27.

GLG LLC first reported a position in PFE in Q1 2014 and has held it in 16 quarters since. The position peaked at $63.9M in Q4 2014. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • GLG LLC held 306,820 shares of Pfizer worth $10.5M as of Q4 2017.
  • GLG LLC left its Pfizer share count unchanged in Q4 2017.
  • Pfizer made up 0.76% of GLG LLC's portfolio in Q4 2017, its #27 holding.
  • GLG LLC first reported a position in Pfizer in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Pfizer position peaked at $63.9M in Q4 2014.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.